Inference for possibly misspecified generalized linear models with nonpolynomial-dimensional nuisance parameters
成果类型:
Article
署名作者:
Hong, Shaoxin; Jiang, Jiancheng; Jiang, Xuejun; Wang, Haofeng
署名单位:
Shandong University; University of North Carolina; University of North Carolina Charlotte; Southern University of Science & Technology
刊物名称:
BIOMETRIKA
ISSN/ISSBN:
0006-3444
DOI:
10.1093/biomet/asae024
发表日期:
2024
页码:
13871404
关键词:
nonconcave penalized likelihood
variable selection
confidence-regions
Lasso
regression
ratio
regularization
RECOVERY
tests
摘要:
It is routine practice in statistical modelling to first select variables and then make inference for the selected model as in stepwise regression. Such inference is made upon the assumption that the selected model is true. However, without this assumption, one would not know the validity of the inference. Similar problems also exist in high-dimensional regression with regularization. To address these problems, we propose a dimension-reduced generalized likelihood ratio test for generalized linear models with nonpolynomial dimensionality, based on quasilikelihood estimation that allows for misspecification of the conditional variance. The test has nearly oracle performance when using the correct amount of shrinkage and has robust performance against the choice of regularization parameter across a large range. We further develop an adaptive data-driven dimension-reduced generalized likelihood ratio test and prove that, with probability going to one, it is an oracle generalized likelihood ratio test. However, in ultrahigh-dimensional models the penalized estimation may produce spuriously important variables that deteriorate the performance of the test. To tackle this problem, we introduce a cross-fitted dimension-reduced generalized likelihood ratio test, which is not only free of spurious effects, but robust against the choice of regularization parameter. We establish limiting distributions of the proposed tests. Their advantages are highlighted via theoretical and empirical comparisons to some competitive tests. An application to breast cancer data illustrates the use of our proposed methodology.